CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.17
+0.09 (1.27%)
At close: Apr 7, 2026, 4:00 PM EDT
7.35
+0.18 (2.51%)
Pre-market: Apr 8, 2026, 5:35 AM EDT

CorMedix Revenue

In the year 2025, CorMedix had annual revenue of $311.71M with 617.03% growth. CorMedix had revenue of $128.62M in the quarter ending December 31, 2025, with 312.10% growth.

Revenue (ttm)
$311.71M
Revenue Growth
+617.03%
P/S Ratio
1.82
Revenue / Employee
$1,631,984
Employees
191
Market Cap
566.79M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025311.71M268.24M617.03%
Dec 31, 202443.47M--
Dec 31, 2023---
Dec 31, 202265.41K-125.53K-65.74%
Dec 31, 2021190.94K-48.30K-20.19%
Dec 31, 2020239.23K-44.04K-15.55%
Dec 31, 2019283.27K-146.53K-34.09%
Dec 31, 2018429.80K100.47K30.51%
Dec 31, 2017329.33K105.22K46.95%
Dec 31, 2016224.11K13.98K6.65%
Dec 31, 2015210.13K20.86K11.02%
Dec 31, 2014189.27K187.27K9,358.97%
Dec 31, 20132.00K--
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group418.63M
Valneva SE205.07M
Zevra Therapeutics106.47M
Prothena Corporation9.68M
Prime Medicine4.63M
Upstream Bio2.85M
ProKidney893.00K
Revenue Rankings